GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AngioLab Inc (XKRX:251280) » Definitions » DeferredTaxAndRevenue

AngioLab (XKRX:251280) DeferredTaxAndRevenue : ₩0 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is AngioLab DeferredTaxAndRevenue?

Deferred Tax And Revenue represents the current portion of obligations, which is a liability that usually would have been paid but is now pas due.

AngioLab's current deferred tax and revenue for the quarter that ended in Dec. 2024 was ₩0 Mil.

AngioLab DeferredTaxAndRevenue Historical Data

The historical data trend for AngioLab's DeferredTaxAndRevenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AngioLab DeferredTaxAndRevenue Chart

AngioLab Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue
Get a 7-Day Free Trial - - - - -

AngioLab Semi-Annual Data
Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
DeferredTaxAndRevenue Get a 7-Day Free Trial - - - - -

AngioLab DeferredTaxAndRevenue Related Terms

Thank you for viewing the detailed overview of AngioLab's DeferredTaxAndRevenue provided by GuruFocus.com. Please click on the following links to see related term pages.


AngioLab Business Description

Traded in Other Exchanges
N/A
Address
65 Techno 3ro, Suite 159, Hanshin S Mecca, Yuseong-gu, Doejeon, CHN
AngioLab Inc is a biotechnology company. It develops products based on angiogenesis inhibitors. It discovers, develops, and markets anti-angiogenic candidates to inhibit the abnormal growth of new blood vessel.

AngioLab Headlines

No Headlines